University of Texas M. D. Anderson Cancer Center - Investigational Cancer Therapeutics is a clinical research site located in Houston, Texas, United States 77030.
Crixeo Health Trust Score: 61/100 (FAIR). This profile has not yet been claimed by the site owner.
University of Texas M. D. Anderson Cancer Center - Investigational Cancer Therapeutics has participated in 3 clinical trials with 2 currently active.
Therapeutic areas: Metastatic or Locally Advanced Unresectable Solid Tumors, Breast Cancer, Solid Tumors.
Sponsors: EMD Serono Research & Development Institute, Inc., Daiichi Sankyo.
Trust Score: 61/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
University of Texas M. D. Anderson Cancer Center - Investigational Cancer Therapeutics has a Crixeo Trust Score of 61/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
University of Texas M. D. Anderson Cancer Center - Investigational Cancer Therapeutics has 3 clinical trials on record, with 2 currently active. Their work covers Metastatic or Locally Advanced Unresectable Solid Tumors, Breast Cancer, Solid Tumors.
University of Texas M. D. Anderson Cancer Center - Investigational Cancer Therapeutics has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.